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Abstract
The 6
th Benelux Bioinformatics Conference (BBC11) held in Luxembourg on 12 and 13 December 2011 attracted
around 200 participants, including internationally-renowned guest speakers and more than 100 peer-reviewed
submissions from 3 continents. Researchers from the public and private sectors convened at BBC11 to discuss
advances and challenges in a wide spectrum of application areas. A key theme of the conference was the
contribution of bioinformatics to enable and accelerate translational and clinical research. The BBC11 stressed the
need for stronger collaborating efforts across disciplines and institutions. The demonstration of the clinical
relevance of systems approaches and of next-generation sequencing-based measurement technologies are among
the existing opportunities for increasing impact in translational research. Translational bioinformatics will benefit
from research models that strike a balance between the importance of protecting intellectual property and the
need to openly access scientific and technological advances. The full conference proceedings are freely available at
http://www.bbc11.lu.
Keywords: Translational bioinformatics, Clinical bioinformatics, Translational research, Systems biology, Next-genera-
tion sequencing, Bioinformatic infrastructure
Background
In a time full of possibilities and expectations for perso-
nalised medicine, bioinformatics represents more than a
technological convergence point at the intersection of
various research fields.
Bioinformatics has become a bridge of integration. A
continuous integration of information, insights and
teams all over the planet. But it also catalyzes the trans-
lation of advances from the computing into the life
sciences, and from there to the clinic, and back. Bioin-
formatics is gradually expanding its potential to improve
the life of patients everywhere, through the transforma-
tion of fundamental discoveries into advanced
approaches to preventing, detecting and treating disease
[1,2].
We met at The 6
th BeNeLux Bioinformatics Confer-
ence (http://www.bbc11.lu, 12 and 13 December 2011,
Luxembourg) to review advances, reflect on challenges
and celebrate the contributions of bioinformatics in a
“post-genome” era. The conference attracted around 200
participants, including internationally-renowned guest
speakers and more than 100 peer-reviewed abstract sub-
missions from 3 continents.
Bioinformatics can answer “when”, “what if” and
“why” questions
Our programme of guest and selected oral and poster
presentations comprised a diverse range of biologically
and clinically relevant questions, computing approaches
and applications [3]. These sessions were driven also by
a significant interest in discussing challenges and direc-
tions for enhancing the impact of bioinformatics in fun-
damental and translational biomedical research. These
features were specially reflected in the presentations
given by our guest speakers: Burkhard Rost (Technical
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Planck-Institut Informatik, Germany), Ioannis Xenarios
(Swiss Institute of Bioinformatics, Switzerland), and
Peter van der Spek (Erasmus Medical Center, The
Netherlands).
Presentations and discussions addressed applications
of significant relevance to the detection and treatment
of cancers, infectious, neurodegenerative and cardiovas-
cular diseases. The meeting also showcased progress in
bioinformatic infrastructures and enabling technologies.
Examples of the latter included next-generation sequen-
cing tools and applications, complex information inte-
gration and annotation over the Web, and several
disease- and organism-specific research resources.
Among such a diversity of approaches and applica-
tions, a crucial pattern can be discerned. Bioinformatics
research is putting a great emphasis on answering
“when”, “what if” and “why” questions using different
types of biological data. When are complex events at the
molecular and systems levels taking place ? When are
specific disease states likely to occur? Thomas Len-
gauer’s talk on translational bioinformatics in treating
HIV infections represented an instance in this direction.
What if specific perturbations are induced ? Why are
observed associations or predictions biologically mean-
ingful ? Ioannis Xenarios’s talk on gene and cellular reg-
ulatory network models was an example within this
research question category.
Different presentations also highlighted opportunities
for integrating multiples vistas of biological phenomena
as dynamic webs of interactions. Examples of this
included: “Visualizing genotype-phenotype relationships
across cell cycle and evolutionary time scales” (Maria
Secrier and Reinhard Schneider), “Prediction of a phos-
phorylation network in Arabidopsis thaliana” (Kris Lau-
kens et al.) and “Interfering with the interaction
network of adenyl cyclase virulence factors” (Therese
Malliavin et al.). This and future contributions would
not be possible without advanced capabilities in large-
scale data analysis and interpretation, for example from
next-generation sequencing experiments (Alejandro
Sifrim et al.; Tim de Meyer et al.) and from other types
of “omic” data (Yan Wu et al.; Alexey Stukalov et al.).
Harnessing the huge amounts of data routinely pro-
duced by high-throughput techniques remains a chal-
lenge, as demonstrated by some of the posters presented
during the conference. While microarrays still represent
a fair amount of the contributions in genomics, next-
generation sequencing has begun its journey towards
clinical applications. This is happening thanks to the
development of affordable, robust and well-standardized
pipelines available for service, as introduced in “Union
makes strength: building baseline Tracks from 69 open
access full human genomes” (Stephane Plaisance and
Mark Veugelers). Having all this information available,
efforts are being put in its “organisation": building path-
ways, modelling networks, analysing interactions, and
prioritising candidates for further downstream valida-
tion. “Analyzing gene and protein expression variance in
cellular pathways using high-throughput experimental
data” (Enrico Glaab and Reinhard Schneider) and “Net-
work analysis of differential expression for drug target
prioritization” (Griet Laenen et al.) are examples of
work in this direction. Given all the methods proposed,
it is also worthwhile to compare how they perform, as
demonstrated in “Critical assessment of candidate gene
prioritization methods” (Daniela Bîrnigen et al.).
Another remarkable point is how bioinformatics is
expanding beyond research environments to reach the
clinicians directly: “Breaching the surface with HOPE”
(Jules Kerssemakers) aims at abstracting the complexity
behind resources dealing with protein interfaces, sur-
faces and assemblies, thus helping physicians to under-
stand the structural effects of mutations. Furthermore,
one of the three awarded posters, “Clinical data miner -
an electronic data capture software framework that
improves interrater agreement” (Arnaud Installé et al.),
was specifically aimed at the routine clinical environ-
ment. The proposed method enhances expert robustness
and facilitates interpretation in situations where “case
report forms” are used.
Perspectives
Presentations and a panel-driven debate on “Technologi-
cal and Cooperation Challenges in Bioinformatics”
offered crucial insights into the state of our field, includ-
ing critical research directions and advances to watch in
the short and longer terms.
The need for cross-disciplinary cooperation in bioin-
formatics and in its different application domains is
unassailable. If we want to develop new tools to improve
human health in fundamental and clinical routine set-
tings, new ways to share data and software will be
essential. Many of such collaborations will ultimately be
b e n e f i t t e df r o md i f f e r e n tl e vels of data integration and
access to high-performance computing. The selection of
specific tools and approaches will continue being driven
by domain-specific biological questions and computing
requirements. For example, the use of cloud computing
technologies cannot be seen as an “one-fits-all” solution
in fundamental or translational biomedical research.
The size and complexity of many projects requiring, for
example, large-scale software development and integra-
tive data mining demand a deeper involvement of area
e x p e r t si nk e ys t e p sa n dd e c i s i o n so ft h et r a n s l a t i o n a l
research cycle.
Researchers are incrementally breaking new ground to
demonstrate the relevance of systems biology
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plings between in silico, in vitro and in vivo models.
Although the estimation of the clinical relevance and
utility of the majority of findings reported to date will
require significant efforts, areas such as disease biomar-
ker discovery and drug target prediction offer fertile
ground for progress in the near future. The latter will
be greatly facilitated by better access to carefully anno-
tated sample cohorts (biobanking) and by the availability
of user-friendly bioinformatic infrastructures.
The potential impact of bioinformatics in translational
and clinical research will also depend on our capacity to
harmonise the needs for freely publishing research out-
puts and for protecting intellectual property. This is par-
ticularly critical taking into account the advantages and
opportunities offered by open-source development and
open-access publishing.
Bioinformatics will be expected to contribute new
ways to streamline the discovery pipeline needed for the
development of diagnostics and drugs in the face of
high costs and stringent regulatory standards. This will
be possible through advances in the interrogation and
simulation of complex dynamic systems, and based on
the capacity of such models and resulting analyses to be
reproduced and independently validated.
Conclusions
The 6
th BeNeLux Bioinformatics Conference discussed
advances and challenges in bioinformatics across a
diverse range of applications. A key theme of the confer-
ence was the mission and roles of bioinformatics in
enabling translational and clinical research. Although we
did not intend to provide an in-depth discussion of
opportunities and challenges in translational bioinfor-
matics, a number of important perspectives were derived
from the conference and deserved to be highlighted in
this article. Major opportunities and challenges include
the extraction of biological meaning from next-genera-
tion sequencing and other high-throughput “omic” tech-
nologies, the development of user-friendly bioinformatic
infrastructure and the demonstration of the clinical rele-
vance of systems-based approaches.
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